Mehdi Fazlalipour

Dr. Mehdi Fazlalipour

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2016 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
DADalileh Aslani
Dalileh Aslani
MSMostafa Salehi-Vaziri
Mostafa Salehi-Vaziri
VBVahid Baniasadi
Vahid Baniasadi
TJTahmineh Jalali
Tahmineh Jalali
SASanam Azad-Manjiri
Sanam Azad-Manjiri
MFMehdi Fazlalipour
Mehdi Fazlalipour

31 December 2012 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
HKHossein Keyvani
Hossein Keyvani
MFMehdi Fazlalipour
Mehdi Fazlalipour
SMSeyed Hamid Reza Monavari
Seyed Hamid Reza Monavari
SMSeyed Hamidreza Monavari
Seyed Hamidreza Monavari
Background: Hepatitis C virus (HCV) causes acute and chronic human hepatitis infection and as such is an important global health problem. The virus was discovered in the USA in 1989 and it is now known that three to four million people are infected every year, WHO estimating that 3 percent of the 7 billion people worldwide being chronically infected. Humans are the natural hosts of HCV and this virus can eventually lead to permanent liver damage and carcinoma. HCV is a member of the Flaviviridae family and Hepacivirus genus. The diameter of the virus is about 50-60 nm and the virion contains a single-stranded positive RNA approximately 10,000 nucleotides in length and consisting of one ORF which is encapsulated by an external lipid envelope and icosahedral capsid. HCV is a heterogeneous virus, classified into 6 genotypes and more than 50 subtypes. Because of the genome variability, nucleotide sequences of genotypes differ by approximately 31-34%, and by 20-23% among subtypes. Quasi-species of mixed virus populations provide a survival advantage for the virus to create multiple variant genomes and a high rate of generation of variants to allow rapid selection of mutants for new environmental conditions. Direct contact with infected blood and blood products, sexual relationships and availability of injectable drugs have had remarkable effects on HCV epidemiology. Hundreds of thousands of people die each year from hepatitis and liver cancer caused by HCV virus infection. Approximately 80% of patients with acute hepatitis C progress into a chronic disease state leading to serious hepatic disorders, 10-20% of which develop chronic liver cirrhosis and hepatocellular carcinoma. The incubation period of HCV is 6-8 weeks and the infection is often asymptomatic so it is very hard to detect at early stages, making early treatment very difficult. Therefore, hepatitis C is called a "silent disease". Neutralizing antibodies are produced against several HCV proteins during infection but the virus mutates to escape from antibodies. Some patients with chronic hepatitis C may have some symptoms such as fatigue, muscle aches, nausea and pain. Autoimmune and immunecomplex-mediated diseases have also been reported with chronic HCV infection.

18 April 2015 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
MFMehdi Fazlalipour
Mehdi Fazlalipour
HKHossein Keyvani
Hossein Keyvani
SMSeyed Hamid Reza Monavari
Seyed Hamid Reza Monavari
SMSeyed Hamidreza Monavari
Seyed Hamidreza Monavari
Background: Gradual development of a useful vaccine can be the main point in the control and eradication of Hepatitis C virus (HCV) infection. Hepatitis C Virus envelope glycoproteins are considered as the main HCV vaccine candidate. Objectives: In this study, the Pichia pastoris expression system was used to express a recombinant HCV CoreE1E2 protein, which consists of Core (269 nt-841nt) E1 (842 nt-1417nt) and E2 (1418 nt-2506nt). Materials and Methods: By a codon optimization technique based on the P. pastoris expression system, we could increase the rate of recombinant proteins. Moreover, the purified protein can efficiently induce anti-CoreE1E2 antibodies in rabbits, and also by developing a homemade Enzyme-Linked ELISA kit we can detect antibody of HCV Iranian patients with genotype 1a. Results: In our study, the virus-like particle of rCoreE1E2 with 70 nm size, was shown by Electron microscopy and proved the self-assembly in vitro in a yeast expression system. Conclusions: These findings of the present study indicate that the recombinant CoreE1E2 glycoprotein is effective in inducing neutralizing antibodies, and is an influential HCV vaccine candidate. Keywords: Hepatitis C Virus (HCV); Virus Like Particles; Pichia pastoris; Recombinant Core-E1-E2 Glycoprotein

MSMostafa Salehi-Vaziri
Mostafa Salehi-Vaziri
MPMohammad Hassan Pouriayevali
Mohammad Hassan Pouriayevali
SASanam Azad-Manjiri
Sanam Azad-Manjiri
AVAbbas Ahmadi Vasmehjani
Abbas Ahmadi Vasmehjani
VBVahid Baniasadi
Vahid Baniasadi
MFMehdi Fazlalipour
Mehdi Fazlalipour
Tick-borne encephalitis virus (TBEV) is a neurotropic tick-borne virus circulating in vast geographical areas of the northern hemisphere. Although the prese ...

11 December 2016 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
MSMostafa Salehi-Vaziri
Mostafa Salehi-Vaziri
SSShokrollah Salmanzadeh
Shokrollah Salmanzadeh
VBVahid Baniasadi
Vahid Baniasadi
TJTahmineh Jalali
Tahmineh Jalali
TMTahereh Mohammadi
Tahereh Mohammadi
MFMehdi Fazlalipour
Mehdi Fazlalipour
Introduction: Crimean-Congo hemorrhagic fever (CCHF) is an acute viral zoonotic disease, which is endemic in vast geographic areas including the Middle East. The causative agent, Crimean-Congo hemorrhagic fever virus (CCHFV), is a Nairovirus, which is mainly transmitted to human from infected hard ticks and viremic livestock. Case Presentation: In April 2016, an outbreak of CCHF occurred in Khuzestan province, Iran, because of slaughtering a tick-infested calf and manipulation of its meat. Discussion: Given that viremic livestock are the main source of CCHF outbreaks in Iran, limitation of the livestock smuggling and unhealthy slaughtering is of great importance in the prevention of CCHF in endemic regions. Keywords: Crimean-Congo Hemorrhagic Fever; Disease Outbreaks; Iran

16 April 2021 in Health Policy and Technology
Verified
Journal Article
Closed access
MSMostafa Salehi-Vaziri
Mostafa Salehi-Vaziri
AAArash Arashkia
Arash Arashkia
EMEhsan Mostafavi
Ehsan Mostafavi
TJTahmineh Jalali
Tahmineh Jalali
MPMohammad Hassan Pouriayevali
Mohammad Hassan Pouriayevali
KAKayhan Azadmanesh
Kayhan Azadmanesh